Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TCT 2021 | OPTIMUM: Surgically Ineligible Patients with Complex Anatomy: Do We Accept the Case?

In surgically ineligible patients with complex coronary anatomy short term risk of death with PCI is considerably lower than the estimated surgical risk. These are the outcomes of the OPTIMUM registry, presented during the TCT scientific sessions. 

TCT 2021 | OPTIMUM: Anatomía compleja y no elegibles para cirugía ¿aceptamos el caso?

The good short-term outcomes highlight the importance of trying percutaneous revascularization to treat complex patients

The current data brought to us by the OPTIMUM results extremely useful, seeing as these patients have been systematically excluded from randomized studies in the last years. 

The OPTIMUM registry included 750 patients with multivessel or left main disease ruled out for surgery and therefore treated with PCI. 

This population was at high risk: 57% had diabetes, 48.2% prior MI, 32.8% prior revascularization and 16.4% prior surgery.

In addition, over one third had chronic kidney failure and 25% was in functional class III/IV.

Chronic total occlusions were fairly common, reaching almost 60%.

Mean Syntax score was 32.4, but nearly half scored >33 (45.3%).


Read also: TCT 2021 | iFR-SWEDEHEART: 5 Years to Trust FFR Is Equivalent to iFR.


At 30 days mortality resulted 5.6%, very similar to the estimated by STS with 5.3% and by EuroSCORE with 5.7%.

Between survivors at 6 months there was significantly improved quality of life and angina frequency. 

Original Title: Outcomes of percutaneous revascularization for the management of surgically ineligible patients with multivessel or left main coronary artery disease: primary results from the OPTIMUM registry.

Reference: Kandzari DE et al. Presentado en el congreso TCT 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...